sellWeak10b5-1 plan
William Hoffman sold $12M of NARI
President and CEO at Inari Medical, Inc.. 200,000 shares at an average of $60.47, traded Jan 6, 2025, filed Jan 8, 2025.
Warning score
30Value
$12M
200,000 shares
Holdings after
238,987
-46% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$12.1M at market
- +10Share of holdings soldSold 46% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-25-001038, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 6, 2025 | SOpen-market sale Common Stock10b5-1 | -141,075 | $60.13 | $8.5M | 297,912 | Jan 8, 2025 |
| Jan 6, 2025 | SOpen-market sale Common Stock10b5-1 | -58,925 | $61.27 | $3.6M | 238,987 | Jan 8, 2025 |
Related signals
Other insiders at Inari Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | Inari Medical, Inc. | Andrew Hykes President and CEO | $166k 3,000 shares | -1% | |
| 40Moderate | Inari Medical, Inc. | William Hoffman President and CEO | $3.3M 60,000 shares | -12% | |
| 22Weak | Inari Medical, Inc. | Thomas Tu Chief Medical Officer | $220k 4,000 shares | -1% | |
| 24Weak | Inari Medical, Inc. | Andrew Hykes President and CEO | $152k 3,000 shares | -1% | |
| 33Weak | Inari Medical, Inc. | William Hoffman President and CEO | $3.1M 60,000 shares | -11% | |
| 28Weak | Inari Medical, Inc. | William Hoffman President and CEO | $2.0M 40,000 shares | -7% | |
| 24Weak | Inari Medical, Inc. | Andrew Hykes President and CEO | $150k 3,000 shares | -1% | |
| 28Weak | Inari Medical, Inc. | William Hoffman President and CEO | $1.8M 40,000 shares | -6% | |
| 28Weak | Inari Medical, Inc. | William Hoffman President and CEO | $1.8M 40,000 shares | -6% | |
| 6Weak | Inari Medical, Inc. | Mitch C. Hill Chief Financial Officer | $135k 3,000 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.